Literature DB >> 22642470

The inside story of dendritic cell immunotherapy.

M-L Alegre, L L Molinero.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22642470      PMCID： PMC3933448          DOI： 10.1111/j.1600-6143.2012.04064.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN： 1600-6135            Impact factor:   8.086


× No keyword cloud information.
  5 in total

1.  Dendritic cell therapies in transplantation revisited: deletion of recipient DCs deters the effect of therapeutic DCs.

Authors:  Z Wang; S J Divito; W J Shufesky; T Sumpter; H Wang; O A Tkacheva; W Wang; C Liu; A T Larregina; A E Morelli
Journal:  Am J Transplant       Date:  2012-04-14       Impact factor: 8.086

Review 2.  Recent developments in cancer vaccines.

Authors:  Karolina Palucka; Hideki Ueno; Jacques Banchereau
Journal:  J Immunol       Date:  2011-02-01       Impact factor: 5.422

Review 3.  Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosis.

Authors:  Danielle M Turley; Stephen D Miller
Journal:  Results Probl Cell Differ       Date:  2010

4.  Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity.

Authors:  Caspar Ohnmacht; Andrea Pullner; Susan B S King; Ingo Drexler; Stefanie Meier; Thomas Brocker; David Voehringer
Journal:  J Exp Med       Date:  2009-02-23       Impact factor: 14.307

5.  Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation.

Authors:  Miriam Beer Torchinsky; Johan Garaude; Andrea P Martin; J Magarian Blander
Journal:  Nature       Date:  2009-03-05       Impact factor: 69.504
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.